Fundraising FoxBoston Harbor Angels — 2018 Investments
3 investments dated 2018 · listed companies and verified rows first · show all
Landsdowne Labs develops button battery technology that deactivates batteries after accidental ingestion to address health risks.
Deep TechHealthtechMedical DevicesNew MaterialsStamford, US
Jeffrey Karp(Executive Officer, Promoter)inRobert Langer(Director, Promoter)Bryan Laulicht(Executive Officer, Promoter)inMelissa Fensterstock(Executive Officer, Director, Promoter)in
BoardDaniel Goldberg(Director)Patrick O'Neill(Director)
Co-investorsConnecticut InnovationsGaingelsHBS Angels of BostonMEDA AngelsTaihill Venture
__Twitter.png)
RevBio develops a biomimetic bone adhesive platform derived from marine biology for bone repair and regenerative applications across dental, orthopedic, and neurosurgical indications.
BiotechHealthtechMedical DevicesNew MaterialsLowell, US
Brian Hess(Chief Executive Officer, Founder)inD. GRAYSON ALLEN(Executive Officer, Director)in
BoardKEVIN FOLEY(Director)GEORGE KAY(Director)
Co-investorsArieal Southeast Angel PartnersBeacon Angels
Siamab Therapeutics is a biopharmaceutical company developing therapeutic antibodies that target tumor-associated carbohydrate antigens (glycans) found on solid tumors such as ovarian, pancreatic, prostate, colon, and breast cancers.
BiotechHealthtechNewton, US
Jeffrey Behrens(Executive Officer, Director)Sundar Subramaniam(Executive Officer, Director)
BoardRobert Mashal(Director)Brad Curley(Director)Gary Pforzheimer(Director)Peter Kroon(Director)
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.